早期癌症动态模型揭示了潜在风险的变化和人口查的影响
Navid Mohammad Mirzaei1, Chin Hur2, Mary Beth Terry3
1Mailman School of Public Health, Columbia University, New York, NY, United States.
Cancer research
|August 29, 2025
概括
早期癌症的增加可能是由于真正的风险增加, 一个新型纳入瘤大小表明加速癌症的发展和乳腺,结肠直肠和甲状腺癌的风险更高在最近的出生队伍.
科学领域:
- 癌症学
- 流行病学
- 生物统计学
背景情况:
- 早期癌症发病率上升 (诊断年龄小于50岁) 促使对明显与真实的风险增加进行调查.
- 传统的癌症模型通常假定在第一个恶性细胞检测时, 不考虑诊断的改善或瘤的大小.
研究的目的:
- 开发和验证一种新的多阶段克隆扩张 (MSCE) 模型,将瘤大小纳入诊断,以区分明显的和真实的早期癌症发病率增加.
- 对结直肠,乳腺和甲状腺癌的癌症风险和检测动态的变化 (1950-1984) 的评估.
主要方法:
- 引入了增强的MSCE框架,明确纳入瘤大小诊断,以便随着时间的推移改善癌症检测.
- 在三个出生队列中应用了精细化的模型来分析结直肠,乳腺和甲状腺癌的发病率数据.
- 评估模型在区分真实风险增加与检测文物方面的表现,并评估查影响.
主要成果:
- 与经典模型相比,增强的MSCE模型证明了结构识别和参数估计的优越性.
- 分析显示,研究癌症的近期出生群体的致癌事件加快,平均停留时间缩短.
- 模型应用支持近年来乳腺癌,结肠直肠癌和甲状腺癌的早期癌症风险的真正增加.
结论:
- 纳入瘤大小诊断对于精确的癌症建模至关重要,使得检测改进和真正的风险变化之间有区别.
- 调查结果支持最近出生的人群中早期癌症风险的真正增加,特别是乳腺癌,结肠直肠癌和甲状腺癌.
- 这种精细的建模方法为癌症病因和查干预措施的影响提供了宝贵的见解.
相关概念视频
01:21Cancer Survival Analysis
448
Cancer survival analysis focuses on quantifying and interpreting the time from a key starting point, such as diagnosis or the initiation of treatment, to a specific endpoint, such as remission or death. This analysis provides critical insights into treatment effectiveness and factors that influence patient outcomes, helping to shape clinical decisions and guide prognostic evaluations. A cornerstone of oncology research, survival analysis tackles the challenges of skewed, non-normally...
448
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
174
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
174
01:24Kaplan-Meier Approach
258
The Kaplan-Meier estimator is a non-parametric method used to estimate the survival function from time-to-event data. In medical research, it is frequently employed to measure the proportion of patients surviving for a certain period after treatment. This estimator is fundamental in analyzing time-to-event data, making it indispensable in clinical trials, epidemiological studies, and reliability engineering. By estimating survival probabilities, researchers can evaluate treatment effectiveness,...
258